AAAAAA
Results:
1-12
|
Results: 12
Authors:
UCKUN FM
CHELSTROM LM
TUELAHLGREN L
DIBIRDIK I
IRVIN JD
LANGLIE EC
MYERS DE
Citation: Fm. Uckun et al., TXU (ANTI-CD7)-POKEWEED ANTIVIRAL PROTEIN AS A POTENT INHIBITOR OF HUMAN-IMMUNODEFICIENCY-VIRUS, Antimicrobial agents and chemotherapy, 42(2), 1998, pp. 383-388
Authors:
WAURZYNIAK B
SCHNEIDER EA
TUMER N
YANISHEVSKI Y
GUNTHER R
CHELSTROM LM
WENDORF H
MYERS DE
IRVIN JD
MESSINGER Y
EK O
ZEREN T
LANGLIE MC
EVANS WE
UCKUN FM
Citation: B. Waurzyniak et al., IN-VIVO TOXICITY, PHARMACOKINETICS, AND ANTILEUKEMIC ACTIVITY OF TXU (ANTI-CD7)-POKEWEED ANTIVIRAL PROTEIN IMMUNOTOXIN, Clinical cancer research, 3(6), 1997, pp. 881-890
Authors:
UCKUN FM
YANISHEVSKI Y
TUMER N
WAURZYNIAK B
MESSINGER Y
CHELSTROM LM
LISOWSKI EA
EK O
ZEREN T
WENDORF H
LANGLIE MC
IRVIN JD
MYERS DE
FULLER GB
EVANS W
GUNTHER R
Citation: Fm. Uckun et al., PHARMACOKINETIC FEATURES, IMMUNOGENICITY, AND TOXICITY OF B43(ANTI-CD19)-POKEWEED ANTIVIRAL PROTEIN IMMUNOTOXIN IN CYNOMOLGUS MONKEYS, Clinical cancer research, 3(3), 1997, pp. 325-337
Authors:
MESSINGER Y
YANISHEVSKI Y
AVRAMIS VI
EK O
CHELSTROM LM
GUNTHER R
MYERS DE
IRVIN JD
EVANS W
UCKUN FM
Citation: Y. Messinger et al., TREATMENT OF HUMAN B-CELL PRECURSOR LEUKEMIA IN SCID MICE USING A COMBINATION OF THE INVESTIGATIONAL BIOTHERAPEUTIC AGENT B43-PAP WITH CYTOSINE-ARABINOSIDE, Clinical cancer research, 2(9), 1996, pp. 1533-1542
Authors:
GUNTHER R
CHELSTROM LM
WENDORF HR
SCHNEIDER EA
COVALCIUC K
JOHNSON B
CLEMENTSON D
IRVIN JD
MYERS DE
UCKUN FM
Citation: R. Gunther et al., TOXICITY PROFILE OF THE INVESTIGATIONAL NEW BIOTHERAPEUTIC AGENT, B43(ANTI-CD19)-POKEWEED ANTIVIRAL PROTEIN IMMUNOTOXIN, Leukemia & lymphoma, 22(1-2), 1996, pp. 61
Authors:
WEXLER RR
GREENLEE WJ
IRVIN JD
GOLDBERG MR
PRENDERGAST K
SMITH RD
TIMMERMANS PBMWM
Citation: Rr. Wexler et al., NONPEPTIDE ANGIOTENSIN-II RECEPTOR ANTAGONISTS - THE NEXT-GENERATION IN ANTIHYPERTENSIVE THERAPY, Journal of medicinal chemistry, 39(3), 1996, pp. 625-656
Authors:
MYERS DE
YANISHEVSKI Y
MASSON E
IRVIN JD
EVANS WE
UCKUN FM
Citation: De. Myers et al., FAVORABLE PHARMACODYNAMIC FEATURES AND SUPERIOR ANTILEUKEMIC ACTIVITYOF B43 (ANTI-CD19) IMMUNOTOXINS CONTAINING 2 POKEWEED ANTIVIRAL PROTEIN MOLECULES COVALENTLY-LINKED TO EACH MONOCLONAL-ANTIBODY MOLECULE, Leukemia & lymphoma, 18(1-2), 1995, pp. 93-102
Authors:
WADDICK KG
MYERS DE
GUNTHER R
CHELSTROM LM
CHANDANLANGLIE M
IRVIN JD
TUMER N
UCKUN FM
Citation: Kg. Waddick et al., IN-VITRO AND IN-VIVO ANTILEUKEMIC ACTIVITY OF B43-POKEWEED ANTIVIRAL PROTEIN AGAINST RADIATION-RESISTANT HUMAN B-CELL PRECURSOR LEUKEMIA-CELLS, Blood, 86(11), 1995, pp. 4228-4233
POKEWEED ANTIVIRAL PROTEIN INACTIVATES POKEWEED RIBOSOMES - IMPLICATIONS FOR THE ANTIVIRAL MECHANISM
Authors:
BONNESS MS
READY MP
IRVIN JD
MABRY TJ
Citation: Ms. Bonness et al., POKEWEED ANTIVIRAL PROTEIN INACTIVATES POKEWEED RIBOSOMES - IMPLICATIONS FOR THE ANTIVIRAL MECHANISM, Plant journal, 5(2), 1994, pp. 173-183
Authors:
WEBER MA
GOLDBERG AI
FAISON EP
LIPSCHUTZ K
SHAPIRO DA
NELSON EB
IRVIN JD
Citation: Ma. Weber et al., EXTENDED-RELEASE FELODIPINE IN PATIENTS WITH MILD-TO-MODERATE HYPERTENSION, Clinical pharmacology and therapeutics, 55(3), 1994, pp. 346-352
Authors:
UCKUN FM
MYERS DE
IRVIN JD
KUEBELBECK VM
FINNEGAN D
CHELSTROM LM
HOUSTON LL
Citation: Fm. Uckun et al., EFFECTS OF THE INTERMOLECULAR TOXIN-MONOCLONAL ANTIBODY LINKAGE ON THE INVIVO STABILITY, IMMUNOGENICITY AND ANTILEUKEMIC ACTIVITY OF B43 (ANTI-CD19) POKEWEED ANTIVIRAL PROTEIN IMMUNOTOXIN, Leukemia & lymphoma, 9(6), 1993, pp. 459-476
Authors:
MONZINGO AF
COLLINS EJ
ERNST SR
IRVIN JD
ROBERTUS JD
Citation: Af. Monzingo et al., THE 2.5 ANGSTROM STRUCTURE OF POKEWEED ANTIVIRAL PROTEIN, Journal of Molecular Biology, 233(4), 1993, pp. 705-715
Risultati:
1-12
|